{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:01:00Z","timestamp":1740135660328,"version":"3.37.3"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T00:00:00Z","timestamp":1618012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T00:00:00Z","timestamp":1618012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ensign Endowment for Gynecologic Cancer Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1245\/s10434-021-09908-w","type":"journal-article","created":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T23:03:29Z","timestamp":1618095809000},"page":"7604-7605","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ASO Author Reflections: Malignant Peritoneal Cytology, Adjuvant Therapy Choice, and Survival in Advanced Endometrial Cancer"],"prefix":"10.1245","volume":"28","author":[{"given":"Shinya","family":"Matsuzaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Klar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6232-8701","authenticated-orcid":false,"given":"Koji","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,10]]},"reference":[{"key":"9908_CR1","doi-asserted-by":"publisher","unstructured":"Matsuo K, Matsuzaki S, Nusbaum DJ, Roman LD, Wright JD, Harter P, Klar M. Association between adjuvant therapy and survival in stage II\u2013III endometrial cancer: influence of malignant peritoneal cytology. Ann Surg Oncol. 2021. https:\/\/doi.org\/10.1245\/s10434-021-09900-4.","DOI":"10.1245\/s10434-021-09900-4"},{"key":"9908_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ejca.2020.08.004","volume":"140","author":"K Matsuo","year":"2020","unstructured":"Matsuo K, Wright JD, Matsuzaki S, Roman LD, Harter P, Klar M. Malignant peritoneal cytology in endometrial cancer: areas of unmet need for evidence. Eur J Cancer. 2020;140:149\u201350.","journal-title":"Eur J Cancer."},{"key":"9908_CR3","unstructured":"Uterine Neoplasms. NCCN Clinical Practice Guidelines in Oncology. Retrieved 20 February 2021 at https:\/\/www.nccn.org\/professionals\/physician_gls\/default.aspx."},{"key":"9908_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","volume":"105","author":"S Pecorelli","year":"2009","unstructured":"Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103\u20134.","journal-title":"Int J Gynaecol Obstet."},{"key":"9908_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ajog.2020.10.045","volume":"224","author":"K Matsuo","year":"2021","unstructured":"Matsuo K, Matsuzaki S, Roman LD, Klar M, Wright JD. Proposal of an endometrial cancer staging schema with stage-specific incorporation of malignant peritoneal cytology. Am J Obstet Gynecol. 2021;224:319\u201321.","journal-title":"Am J Obstet Gynecol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-09908-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-09908-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-09908-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T20:12:10Z","timestamp":1634328730000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-09908-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,10]]},"references-count":5,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["9908"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-09908-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"type":"print","value":"1068-9265"},{"type":"electronic","value":"1534-4681"}],"subject":[],"published":{"date-parts":[[2021,4,10]]},"assertion":[{"value":"24 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Koji Matsuo received funding support from the Ensign Endowment for Gynecologic Cancer Research and also received honorarium from Chugai. Shinya Matsuzaki received research funding from Merck. Funding was provided outside of this work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}